UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
Evidence-Based Colorectal Cancer Screening for the Uninsured
Not Applicable
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Other: FIT Invitation OnlyOther: FIT plus $10 IncentiveOther: FIT plus $5 Incentive
- First Posted Date
- 2013-09-19
- Last Posted Date
- 2020-03-19
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 8565
- Registration Number
- NCT01946282
Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis
Not Applicable
Terminated
- Conditions
- Acute Alcoholic Hepatitis
- Interventions
- Drug: Placebo for ProbioticDietary Supplement: Lactobacillus Rhamnosus GG
- First Posted Date
- 2013-08-14
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT01922895
- Locations
- 🇺🇸
University of Louisville, Louisville, Kentucky, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸U Texas Southwestern Medical Center, Dallas, Texas, United States
Comparison of NovaFerrum® vs Ferrous Sulfate Treatment in Young Children With Nutritional Iron Deficiency Anemia
Phase 4
Completed
- Conditions
- Iron Deficiency Anemia
- Interventions
- Drug: elemental iron (NovaFerrum®)Drug: elemental iron (Ferrous Sulfate)
- First Posted Date
- 2013-07-22
- Last Posted Date
- 2017-12-14
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT01904864
- Locations
- 🇺🇸
Children's Medical Center Dallas, Dallas, Texas, United States
DHA For The Treatment of Pediatric Concussion Related to Sports Injury
Phase 1
Completed
- Conditions
- ConcussionMild Traumatic Brain Injury
- Interventions
- Drug: PlaceboDrug: Docosahexaenoic acid (DHA)
- First Posted Date
- 2013-07-19
- Last Posted Date
- 2021-01-11
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT01903525
- Locations
- 🇺🇸
Sports Medicine at Texas Scottish Rite Hospital for Children, Plano, Texas, United States
High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer
Phase 2
Completed
- Conditions
- Metastatic Clear Cell Renal Cell Carcinoma
- Interventions
- Drug: IL-2Radiation: Stereotactic Ablative Body Radiation Therapy
- First Posted Date
- 2013-07-11
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT01896271
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
A Health Intervention to Prevent Depression Hepatitis C Patients
Phase 2
Terminated
- Conditions
- Major Depressive DisorderHepatitis C
- Interventions
- Behavioral: Health EducationBehavioral: Exercise
- First Posted Date
- 2013-07-01
- Last Posted Date
- 2016-12-29
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 1
- Registration Number
- NCT01890083
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
The Use of Apneic Oxygenation During Prolonged Intubation in Pediatric Patients: a Randomized Clinical Trial
Not Applicable
Completed
- Conditions
- Intubation of Pediatric Dental Surgery Patients
- Interventions
- Device: TrueView PCD Video Laryngoscope
- First Posted Date
- 2013-06-26
- Last Posted Date
- 2019-04-11
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 482
- Registration Number
- NCT01886807
- Locations
- 🇺🇸
Children's Medical Center Dallas, Dallas, Texas, United States
Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension
- First Posted Date
- 2013-05-24
- Last Posted Date
- 2018-05-01
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 76
- Registration Number
- NCT01862497
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
- First Posted Date
- 2013-04-24
- Last Posted Date
- 2021-03-01
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT01838317
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Vilazodone for Corticosteroid-Induced Memory Impairment
Phase 2
Completed
- Conditions
- Memory Impairment
- Interventions
- First Posted Date
- 2013-04-10
- Last Posted Date
- 2019-04-11
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT01828515
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath